子宫内膜异位症与口服避孕药使用者抑郁风险:基于13个国家队列研究的汇总分析
该汇总分析纳入11个欧洲国家、哥伦比亚和澳大利亚的93 541名新开具口服避孕药且无抑郁自报史的女性,比较有或无子宫内膜异位症者的自报抑郁发生率。有子宫内膜异位症者抑郁风险更高(HR 1.85,95%CI 1.60-2.13),但绝对风险增加较小(ARD 23.2/10 000,95%CI 15.2-30.9)。
要点
- 口服避孕药使用者中,有子宫内膜异位症者自报抑郁发生率62.2/10 000(95%CI 55.4-69.5),无者为39.0/10 000(95%CI 35.8-42.5)。
- 有子宫内膜异位症者抑郁风险约为无者的1.85倍(HR 1.85,95%CI 1.60-2.13),绝对风险差23.2/10 000(95%CI 15.2-30.9)。
- 需伤害人数(NNH)为431(95%CI 323.7-657.0),亚组和敏感性分析结果相似。
核心结论
- 在口服避孕药使用者中,有子宫内膜异位症的女性自报抑郁风险高于无子宫内膜异位症者,但绝对风险增加较小。
研究设计与样本
- 二次汇总队列研究,利用两项以患者为中心的纵向研究(INAS-VIPOS和PRO-E2)数据,覆盖11个欧洲国家、哥伦比亚和澳大利亚。
- 纳入93 541名新开具口服避孕药、有或无子宫内膜异位症且无自报抑郁史的女性。
- 基线及此后每6-12个月通过自填问卷采集新发抑郁发作,计算每10 000女性年的发生率,并采用稳定逆概率治疗加权(IPTW)估计粗和调整风险比(HR)。
主要发现
- 93 541名女性中,21 090名有子宫内膜异位症(49 541女性年),72 451名无子宫内膜异位症(137 137女性年)。
- 有子宫内膜异位症者中308名(1.5%)报告抑郁发作,发生率为62.2/10 000(95%CI 55.4-69.5);无子宫内膜异位症者中535名(0.7%)报告抑郁发作,发生率为39.0/10 000(95%CI 35.8-42.5)。
- 绝对风险差(ARD)为23.2/10 000(95%CI 15.2-30.9),需伤害人数(NNH)为431(95%CI 323.7-657.0)。
- 控制年龄、BMI、吸烟、教育程度和初潮年龄后,有子宫内膜异位症者抑郁的HR为1.85(95%CI 1.60-2.13)。
- 亚组和敏感性分析显示相似结果。
临床怎么用
- 作者认为,这些结果突显了在口服避孕药使用者中考虑子宫内膜异位症对心理健康影响的重要性。
- 作者指出,需要进一步研究探讨其他 Contributing 因素和潜在干预措施。
局限性
- 尽管努力控制混杂因素,但仍可能存在残余混杂。
- 结果仅能推广至口服避孕药使用者。
- 需要进一步研究探讨其他 Contributing 因素和潜在干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does endometriosis affect the mental health of women using oral contraceptives? SUMMARY ANSWER: Among oral contraceptive users, women with endometriosis have a higher risk of depression compared to those without endometriosis, although the absolute risk increase is small. WHAT IS KNOWN ALREADY: Previous studies have suggested a potential link between endometriosis and mental health issues, but the impact of endometriosis on depression among oral contraceptive users remains unclear. STUDY DESIGN, SIZE, DURATION: A secondary pooled cohort study utilizing data from two longitudinal patient-centric studies (INAS-VIPOS and PRO-E2) was conducted across 11 European countries, Colombia and Australia. The study included 93 541 women newly prescribed oral contraceptives, with or without endometriosis, and without a self-reported history of depression. PARTICIPANTS/MATERIALS, SETTING, METHODS: Participant's mental health was captured using self-administered questionnaires at baseline and every 6-12 months thereafter, asking about any newly occurred episodes of depression. Incidence rates (IRs) of self-reported depression were calculated per 10 000 woman-years. Absolute risk difference (ARD) and number needed to harm (NNH) were calculated with 95% CIs. The association between endometriosis and self-reported depression was estimated through crude and adjusted hazard ratios (HRs) with 95% CI, using stabilized inverse probability of treatment weighting (IPTW). MAIN RESULTS AND THE ROLE OF CHANCE: Of the included 93 541 women, 21 090 had endometriosis (49 541 woman-years) and 72 451 had no endometriosis (137 137 woman-years.) Of those with endometriosis, 308 (1.5%) reported an episode of depression (IR: 62.2/10 000, 95% CI: 55.4-69.5) compared to 535 (0.7%) of women without endometriosis (IR 39.0/10 000, 95% CI: 35.8-42.5). The ARD and NNH were 23.2 per 10 000 (95% CI: 15.2-30.9) and 431 (95% CI: 323.7-657.0) respectively. The HR of depression in women with endometriosis was 1.85 (95% CI: 1.60-2.13) using stabilized IPTW to control for age, BMI, smoking, education, and age at menarche. Subgroup and sensitivity analyses showed similar results. LIMITATIONS, REASONS FOR CAUTION: While efforts were made to control for confounding factors, residual confounding may still exist. Additionally, the results can only be generalized to users of oral contraceptives. WIDER IMPLICATIONS OF THE FINDINGS: These results highlight the importance of considering the mental health implications of endometriosis among women using oral contraceptives. Further research is needed to explore additional contributing factors and potential interventions. STUDY FUNDING/COMPETING INTEREST(S): No funding was received for this study. No competing interests apply for this research. TRIAL REGISTRATION NUMBER: N/A.
引用
- De Corte P, Milhoranca I, Oberg AS, et al. Endometriosis and risk of depression among oral contraceptive users: a pooled analysis of cohort studies from 13 countries. Hum Reprod. 2025. PMID: 39799971. doi:10.1093/humrep/deae299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。